Novocure Announces 10 Oral Presentations and a Special Session on Tumor Treating Fields at the 41st International Engineering in Medicine and Biology Conference - TC Read more about Novocure Announces 10 Oral Presentations and a Special Session on Tumor Treating Fields at the 41st International Engineering in Medicine and Biology Conference - TC
Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma - TC Read more about Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma - TC
MacroGenics Announces Positive Results from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer - TC Read more about MacroGenics Announces Positive Results from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer - TC
Paratek Pharmaceuticals Broadens Clinical Profile of NUZYRA™ (Omadacycline) with New ECCMID 2019 Data Presentations - TC Read more about Paratek Pharmaceuticals Broadens Clinical Profile of NUZYRA™ (Omadacycline) with New ECCMID 2019 Data Presentations - TC
The Lancet Oncology Publishes Results from Phase 2 QUADRA Clinical Trial of Niraparib - TC Read more about The Lancet Oncology Publishes Results from Phase 2 QUADRA Clinical Trial of Niraparib - TC
Entasis Therapeutics Announces Multiple Data Presentations at ECCMID 2019 - TC Read more about Entasis Therapeutics Announces Multiple Data Presentations at ECCMID 2019 - TC
Paratek Pharmaceuticals Presenting New Data from NUZYRA™ (Omadacycline) Development Program at ECCMID 2019 - TC Read more about Paratek Pharmaceuticals Presenting New Data from NUZYRA™ (Omadacycline) Development Program at ECCMID 2019 - TC
Entasis Therapeutics Initiates Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections - TC Read more about Entasis Therapeutics Initiates Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections - TC
MacroGenics Presented Preclinical Data about Margetuximab at the AACR Annual Meeting 2019 - TC Read more about MacroGenics Presented Preclinical Data about Margetuximab at the AACR Annual Meeting 2019 - TC
Novocure Initiates Phase 3 Pivotal Trial in Recurrent Ovarian Cancer - TC Read more about Novocure Initiates Phase 3 Pivotal Trial in Recurrent Ovarian Cancer - TC